In the first quarter of 2023, insurance reimbursements for medical cannabinoid products in Germany continued to grow, illustrating the ongoing gradual expansion of the country’s cannabis industry, which now ranks among the largest globally. This period’s reimbursement reached approximately 50.9 million euros ($55.6 million), as indicated by the most recent data from the German National
In the first quarter of 2023, insurance reimbursements for medical cannabinoid products in Germany continued to grow, illustrating the ongoing gradual expansion of the country’s cannabis industry, which now ranks among the largest globally. This period’s reimbursement reached approximately 50.9 million euros ($55.6 million), as indicated by the most recent data from the German National […]
Cannabis Law Report
You must log in to post a comment.